Research dossier
Clinical research on Vitamin B12
10 trials reviewed across 6 indications.
Strongest evidence
Anemia and cobalamin-deficiency disease
Mechanism
B12 is required for methionine synthase (DNA synthesis cofactor) and methylmalonyl-CoA mutase (fatty-acid metabolism). Deficiency produces megaloblastic anemia and demyelinating neuropathy.
B12 deficiency causes a real, treatable disease. High-dose oral B12 normalizes hematology and B12 levels comparably to intramuscular injections in most patients with megaloblastic anemia, including pernicious anemia. This is the strongest part of the evidence base — clinical disease, regulatory recognition, well-established treatment.
Severe neurologic involvement or oral dosing failure remain reasons for IM injections. The default for uncomplicated B12 deficiency, including pernicious anemia, can be oral 1,000–2,000 µg/day.
Trials cited
Oral versus intramuscular cobalamin in megaloblastic anemia
Null · RCT
Bolaman et al., 2003, Clinical Therapeuticsn=6060 adults with megaloblastic anemia randomized to high-dose oral versus intramuscular B12. Both arms normalized hematology and B12 levels comparably at 90 days, with oral marginally outperforming IM on a few markers. Confirms that high-dose oral B12 is not inferior to injections for most deficiency cases.
Most adults with B12 deficiency — including pernicious anemia — can be treated with oral high-dose B12. The 'must have injections' framing is outdated for the typical patient. Severe neurologic involvement or absorption that fails on high-dose oral are still IM indications.
B12 supplementation in infants with poor B12 status
mixed · RCT
Strand et al., 2020, PLoS Medicinen=600600 infants in Nepal — a setting with high subclinical B12 deficiency — randomized to daily B12 versus placebo for a year. Neurodevelopmental scores improved on the B12 arm versus placebo, particularly in infants with the lowest baseline status. Reinforces the deficiency-correction story: B12 helps people who are deficient.
Effect concentrated in the deficient subgroup. Findings do not extrapolate to well-nourished infants in high-income settings.
Pregnancy and fetal neurological development
Mechanism
B12 is essential for myelination and DNA synthesis during rapid fetal and infant brain growth. Maternal deficiency raises infant risk of failure to thrive and developmental delay.
Maternal B12 status matters during pregnancy and breastfeeding. Vegan and strictly vegetarian women without B12 supplementation can produce milk with low B12, putting infants at real risk. Standard prenatal vitamins contain B12; the relevant action is taking one and confirming adequate vegan-friendly forms if applicable.
Vegan and strict vegetarian pregnancy is the high-impact population — supplementation is not optional. Omnivorous well-nourished pregnancy meets requirements through diet plus standard prenatal.
B12 supplementation in infants with poor B12 status
mixed · RCT
Strand et al., 2020, PLoS Medicinen=600600 infants in Nepal — a setting with high subclinical B12 deficiency — randomized to daily B12 versus placebo for a year. Neurodevelopmental scores improved on the B12 arm versus placebo, particularly in infants with the lowest baseline status. Reinforces the deficiency-correction story: B12 helps people who are deficient.
Effect concentrated in the deficient subgroup. Findings do not extrapolate to well-nourished infants in high-income settings.
Energy and fatigue
Mechanism
B12 deficiency impairs erythropoiesis (anemia → fatigue) and methylation (one-carbon metabolism). Repletion in deficient adults reliably resolves fatigue.
If you are deficient, B12 fixes the fatigue caused by deficiency — full stop. If you are not deficient, no rigorous trial shows B12 boosts energy in adults with normal status. The 'B12 shot for energy' clinic trend depends entirely on whether you were low to begin with.
Strong effect in documented deficiency. Negligible effect in non-deficient adults. Get a serum B12 (and ideally MMA or homocysteine) before assuming this is your fatigue fix.
Oral versus intramuscular cobalamin in megaloblastic anemia
Null · RCT
Bolaman et al., 2003, Clinical Therapeuticsn=6060 adults with megaloblastic anemia randomized to high-dose oral versus intramuscular B12. Both arms normalized hematology and B12 levels comparably at 90 days, with oral marginally outperforming IM on a few markers. Confirms that high-dose oral B12 is not inferior to injections for most deficiency cases.
Most adults with B12 deficiency — including pernicious anemia — can be treated with oral high-dose B12. The 'must have injections' framing is outdated for the typical patient. Severe neurologic involvement or absorption that fails on high-dose oral are still IM indications.
Cognition in older adults
Mechanism
Severe B12 deficiency causes subacute combined degeneration of the spinal cord and demyelinating cognitive impairment, both reversible if treated early. The mechanism for sub-clinical deficiency affecting cognition is the homocysteine pathway.
Severe B12 deficiency clearly damages cognition and reverses with repletion. Routine B12 supplementation in older adults with mild biochemical deficiency but no anemia or overt neurology has not improved cognition in randomized trials (Eussen 2006, PHS-II multivitamin). The honest read: catch and treat true deficiency promptly; do not expect cognitive benefit from supplementation in the well-nourished.
Treat documented deficiency aggressively. Do not extrapolate the deficiency-treatment evidence to wellness supplementation in non-deficient adults.
Oral B12 in mild deficiency, cognitive function
Null · RCT
Eussen et al., 2006, American Journal of Clinical Nutritionn=195195 older adults with mild B12 deficiency randomized to oral B12 (with or without folate) versus placebo. B12 levels rose substantially. Cognitive function did not improve over 24 weeks. The honest read: correcting mild biochemical deficiency in older adults without anemia or overt neurologic disease did not translate to measurable cognitive gain.
Argues against routine B12 supplementation as a cognitive intervention in adults with subtle biochemical deficiency. Different from frank pernicious anemia, where neurologic recovery on B12 is well established.
Physicians' Health Study II — multivitamin and cognition
Null · RCT
Grodstein et al., 2013, Annals of Internal Medicinen=5947Long-term randomized multivitamin (with B12) versus placebo in 5,947 male physicians ≥65. Average 12 years of follow-up. No effect on cognitive decline or dementia incidence. The largest, longest test of routine multivitamin (including B12) for cognition came back null.
Multivitamin design — cannot attribute the null to B12 specifically. But it underlines the same point: B12 supplementation in a generally well-nourished population doesn't move cognitive endpoints.
FACIT — folic acid and cognition (B12-replete cohort)
positive · RCT
Durga et al., 2007, Lancetn=818818 adults randomized to 800 µg folic acid daily for 3 years. Folate group improved on memory and information-processing speed versus placebo. The trial is foundational for the B-vitamin-cognition story even though the active agent was folate — it sets up the homocysteine-lowering hypothesis that B12 trials extend.
Folate, not B12. Listed because the homocysteine hypothesis underlies most B12-cognition trials. Importantly: serum B12 was normal at baseline — folate works only when B12 isn't the limiting nutrient.
Cardiovascular and stroke prevention
Mechanism
B12 (with folate) lowers homocysteine, which is associated with cardiovascular and stroke risk in observational data. Hypothesis: lower homocysteine → fewer events.
VITATOPS randomized 8,164 stroke survivors to B-vitamins or placebo for 3.4 years. Homocysteine dropped. Composite vascular events did not. Other large trials (HOPE-2, NORVIT, SEARCH) reach similar null conclusions. The homocysteine-lowering vascular-prevention story does not survive randomized testing.
Lowering homocysteine via B-vitamins is not a cardiovascular prevention strategy. Standard CV care — blood pressure, lipids, diet, exercise — does the work.
VITATOPS — B-vitamins for stroke prevention
Null · RCT
VITATOPS Trial Study Group (Hankey), 2010, Lancet Neurologyn=81648,164 stroke/TIA survivors randomized to B-vitamins (B12, folate, B6) versus placebo. Homocysteine dropped substantially. Composite vascular endpoint did not. The big, clean test of homocysteine-lowering for vascular prevention.
B12 lowers homocysteine. Lowering homocysteine via B-vitamin supplementation does not reduce cardiovascular events in the trials that have tested it directly.
B-PROOF — B12 + folate for fracture prevention
negative · RCT
van Wijngaarden et al., 2014, American Journal of Clinical Nutritionn=29192,919 older adults with elevated homocysteine randomized to B12 + folate versus placebo for 2 years. No reduction in osteoporotic fractures. Homocysteine dropped substantially, but the bone outcome did not move. The hypothesis was reasonable; the data closed it.
Subgroup analyses suggested possible benefit in the oldest-old, but the primary endpoint was unambiguously null. Bone outcomes need calcium, vitamin D, and load-bearing exercise — not B12.
Bone health and fracture prevention
Mechanism
Elevated homocysteine is associated with fracture risk in cohort data. Hypothesis was that lowering homocysteine via B12 + folate would reduce fractures.
B-PROOF randomized 2,919 older adults with elevated homocysteine to B12 + folate versus placebo for 2 years. Homocysteine dropped substantially. Fracture incidence did not. The bone hypothesis tested cleanly and failed.
Bone health requires calcium, vitamin D, vitamin K2, and weight-bearing exercise. B12 is not a bone-health intervention.
B-PROOF — B12 + folate for fracture prevention
negative · RCT
van Wijngaarden et al., 2014, American Journal of Clinical Nutritionn=29192,919 older adults with elevated homocysteine randomized to B12 + folate versus placebo for 2 years. No reduction in osteoporotic fractures. Homocysteine dropped substantially, but the bone outcome did not move. The hypothesis was reasonable; the data closed it.
Subgroup analyses suggested possible benefit in the oldest-old, but the primary endpoint was unambiguously null. Bone outcomes need calcium, vitamin D, and load-bearing exercise — not B12.
5 forms of Vitamin B12 compared
Cyanocobalamin
Roughly 50% of an oral 1 µg dose absorbed via intrinsic factor; passive absorption rises with high doses
Best forMost common, cheapest, well-studied form for general repletionSynthetic form converted to active cobalamins in the body. The cyanide moiety is trace and metabolically irrelevant in normal adults — debunked concern. Used in the majority of B12 trials, including the deficiency-treatment standards.
Methylcobalamin
Comparable to cyanocobalamin in head-to-head pharmacokinetic studies
Best forActive coenzyme form; preferred by clinicians focused on neurological casesThe 'pre-activated' framing has marketing weight but limited head-to-head clinical advantage over cyanocobalamin in standard deficiency. Reasonable preference for genuine MTHFR variants or for practitioners who want to skip the conversion step. Costs more.
Hydroxocobalamin
Longer plasma half-life than cyanocobalamin when given by injection
Best forIntramuscular injections in most of Europe; cyanide toxicity reversalThe default injectable B12 in much of Europe. Longer retention means fewer injections per year for maintenance therapy. Also used in pharmacological doses for cyanide poisoning.
Adenosylcobalamin (dibencozide)
Active coenzyme form, less commonly used in supplements
Best forMitochondrial methylmalonyl-CoA mutase pathway; niche useOne of the two active coenzyme forms in the body. Marketed alongside methylcobalamin in 'active B12' formulations. Limited independent trial data.
Sublingual B12 (any form)
Comparable to standard oral dosing in head-to-head trials
Best forDelivery preference, perceived faster absorptionSharabi 2003 found no advantage over oral at 500 µg. Convenient if you struggle with pills, but not biochemically superior. The 'bypasses absorption issues' marketing is overstated.
Are you deficient? Symptoms, risk groups, lab tests
Roughly 6% of adults under 60 and around 20% of adults over 60 have biochemical B12 deficiency or low-normal status. Pernicious anemia (autoimmune intrinsic-factor loss) affects ~2% of adults over 60 and is the classic cause.
Common symptoms
- Persistent fatigue and weakness
- Pale or jaundiced skin
- Tingling, numbness, or pins-and-needles in hands and feet
- Difficulty walking or balance problems
- Glossitis — smooth, sore, red tongue
- Mouth ulcers
- Memory problems and brain fog
- Mood changes — depression, irritability
- Vision changes in advanced deficiency
- Shortness of breath and palpitations from anemia
Who is at risk
Vegans and strict vegetarians
B12 is found almost exclusively in animal foods. Plant foods do not provide reliable B12. Supplementation is not optional in long-term vegans — it is required.
Adults over 60
Atrophic gastritis reduces gastric acid and intrinsic factor production. Up to 20–30% of older adults cannot efficiently absorb food-bound B12. The IOM specifically recommends synthetic B12 (fortified foods or supplements) for adults over 50.
e.g. metformin
Long-term metformin users
Metformin impairs ileal B12 absorption via a calcium-dependent mechanism. Each year of use raises deficiency risk by ~13%; meaningful deficiency hits ~20% of long-term users.
e.g. omeprazole, esomeprazole, pantoprazole, ranitidine, famotidine
Long-term proton pump inhibitor and H2 blocker users
Gastric acid is required to release food-bound B12 from protein. Acid suppression reduces this step. Impact is on food-bound B12, not crystalline supplement B12 — supplements still absorb fine.
Pernicious anemia
Autoimmune destruction of gastric parietal cells eliminates intrinsic-factor production. The classic cause of severe B12 deficiency. Affects roughly 2% of adults over 60. Treatable with high-dose oral or intramuscular B12 for life.
Post-bariatric surgery patients
Roux-en-Y gastric bypass removes most of the stomach and bypasses the duodenum, eliminating both intrinsic-factor production and standard absorption sites. Lifelong B12 supplementation is required.
Crohn's disease and ileal resection
B12 is absorbed in the terminal ileum. Resection or active Crohn's at this site impairs absorption.
Celiac disease
Untreated celiac with mucosal damage impairs B12 absorption. Risk persists during diagnosis and gluten exposure; resolves with mucosal healing.
Heavy alcohol use
Alcohol-related gastritis impairs intrinsic-factor production and B12 absorption. Often combined with poor dietary intake.
e.g. colchicine, neomycin, chloramphenicol
Long-term colchicine, neomycin, or chloramphenicol users
Colchicine and neomycin impair ileal B12 absorption. Chloramphenicol blunts the bone-marrow response to B12 in deficiency states.
Lab markers
Serum B12 (cobalamin)
Serum B12 in the low-normal range (200–350 pg/mL) can mask functional deficiency. Pair with MMA or homocysteine when symptoms suggest deficiency despite borderline serum.
Better:Methylmalonic acid (MMA), Homocysteine, Holotranscobalamin (active B12)
- Deficient
- <200 pg/mL (<148 pmol/L)
- Borderline / functionally deficient
- 200–350 pg/mL — confirm with MMA or homocysteine
- Adequate
- >350 pg/mL (>258 pmol/L)
Methylmalonic acid (MMA)
More specific marker of functional B12 deficiency than serum B12. Elevated when B12 is unavailable to the methylmalonyl-CoA mutase reaction.
- Elevated (suggests deficiency)
- >270 nmol/L
Homocysteine
Elevated in B12 or folate deficiency. Less specific than MMA — also affected by folate, B6, kidney function, and genetics.
- Elevated
- >15 µmol/L
Side effects and drug interactions
Side effects
Acne flare in some users
Uncommon
High-dose B12 (and B6) has been associated with acne in case reports and small series, possibly via skin Cutibacterium response.
Injection-site reactions
Uncommon
Intramuscular B12 can cause local pain, redness, or rare allergic reactions.
Anaphylaxis to cobalamin (rare)
Rare
Genuine cobalamin anaphylaxis has been reported, mostly with intramuscular hydroxocobalamin. Extremely rare.
Transient diarrhea or nausea
Uncommon
Reported with high oral doses; uncommon at standard supplemental dosing.
Restenosis after coronary stenting (signal in one trial)
Rare
One trial of B12 + folate + B6 after coronary stenting found higher restenosis on the active arm. Not consistently replicated.
Drug interactions
Reduces nutrient status
metforminMetformin impairs ileal B12 absorption. Long-term use raises deficiency risk substantially.
Adults on metformin >4 years should have B12 status checked annually. Supplementation is appropriate when status is low or borderline; monitoring is appropriate even with normal status.
Reduces nutrient status
proton pump inhibitorsH2 blockersAcid suppression reduces release of food-bound B12 from dietary protein. Crystalline supplement B12 absorbs normally.
If you take long-term acid suppression, get B12 from supplements or fortified foods rather than relying on dietary protein-bound B12.
Reduces nutrient status
colchicineneomycinpara-aminosalicylic acidThese agents impair B12 absorption in the ileum.
If on chronic therapy, monitor B12 status periodically and supplement if low.
Other
chloramphenicolBlunts the bone-marrow response to B12 supplementation in deficiency.
Rarely co-prescribed in modern practice. If both are needed, follow hematologic response carefully.
Other
high-dose folic acid (≥1 mg/day)Folic acid corrects the megaloblastic anemia of B12 deficiency without correcting the neurologic damage. The classic 'masking' interaction.
Confirm B12 status before taking high-dose folate (>1 mg). Standard prenatal and multivitamin doses (400 µg) are not the same risk.
Other critical caveats
- B12 deficiency can cause permanent neurological damage. Numbness, balance issues, or cognitive symptoms in someone at risk for B12 deficiency need immediate evaluation — not a wait-and-see month.
- Folic acid can mask the anemia of B12 deficiency while the nerve damage continues unchecked. Do not take high-dose folate (≥1 mg/day) without confirming B12 status. This is the single most important B12 safety point.
- Long-term metformin and proton-pump-inhibitor use are routine causes of B12 deficiency in modern medicine — and routinely missed. If you are on either for years, ask your doctor for a B12 (and ideally MMA) check.
- Strict vegan and vegetarian diets without B12 supplementation will eventually cause deficiency. Plant foods do not provide reliable B12. Supplementation in long-term vegans is mandatory, not optional.
- B12 supplementation does not prevent cardiovascular events or fractures. The trials that tested this hypothesis (VITATOPS, B-PROOF) came back null. Do not take B12 for these indications.
Frequently asked
Should I take a B12 supplement?
Depends on whether you are deficient or at risk. Vegans and strict vegetarians: yes, mandatory. Adults over 60: a synthetic B12 source (fortified foods or a multivitamin) is recommended even if your diet looks fine, because absorption efficiency drops with age. Long-term metformin or PPI users: get tested, supplement if low. Healthy omnivorous adults under 60 with a varied diet: routine B12 supplementation has not been shown to do anything useful in trials.Cyanocobalamin or methylcobalamin — which is better?
For most people, cyanocobalamin. It is the form used in the largest trials, including the standard deficiency-treatment evidence base, and it costs a fraction of methylcobalamin. The 'cyanide is bad' framing is not biochemically meaningful at supplemental doses. Methylcobalamin is reasonable if you have a clinically meaningful MTHFR variant or your practitioner specifically prefers an active form, but it is not biochemically superior in routine deficiency repletion.Do B12 injections work better than oral pills?
Not for most people. Head-to-head trials (Bolaman 2003 and later replications) show high-dose oral B12 (1,000–2,000 µg/day) normalizes blood levels comparably to intramuscular injections in most patients with B12 deficiency, including pernicious anemia. Injections still have a role in severe neurologic involvement or when oral dosing has failed, but the 'must have shots' framing is outdated. A daily 1,000 µg oral B12 pill costs pennies and works for the majority.How much B12 do I need?
The RDA is 2.4 µg/day for adults, 2.6 µg in pregnancy, 2.8 µg in lactation. For repletion of biochemical deficiency, oral 1,000–2,000 µg/day for several weeks is the standard regimen. Maintenance after repletion is typically 1,000 µg/day or 1,000 µg every 1–3 months by injection. There is no upper limit set for B12 because excess is excreted in urine — toxicity is not a meaningful concern.Will B12 give me energy if I'm not deficient?
No. The 'B12 shot for energy' clinic trend has no rigorous evidence behind it in non-deficient adults. If your B12 is normal and your fatigue is not B12-related, an injection or supplement will not fix it. If you are deficient, it absolutely fixes the deficiency-related fatigue. The right move is testing first — serum B12 plus MMA or homocysteine if borderline — not assuming.
References
- 01NIH Office of Dietary Supplements — Vitamin B12 Health Professional Fact Sheet
- 02StatPearls — Vitamin B12 Deficiency (NCBI Bookshelf)
- 03American Diabetes Association Standards of Care — metformin and B12 monitoring
Last reviewed2026-05-07